Group One Trading’s Ocular Therapeutix OCUL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$111K Buy
11,950
+5,212
+77% +$48.4K ﹤0.01% 1061
2025
Q1
$49.4K Sell
6,738
-3,198
-32% -$23.4K ﹤0.01% 1138
2024
Q4
$84.9K Sell
9,936
-18,497
-65% -$158K ﹤0.01% 1100
2024
Q3
$247K Sell
28,433
-12,292
-30% -$107K ﹤0.01% 644
2024
Q2
$279K Sell
40,725
-332,578
-89% -$2.27M ﹤0.01% 602
2024
Q1
$3.4M Buy
373,303
+328,904
+741% +$2.99M 0.01% 155
2023
Q4
$198K Buy
44,399
+36,119
+436% +$161K ﹤0.01% 742
2023
Q3
$26K Buy
+8,280
New +$26K ﹤0.01% 1224
2023
Q2
Sell
-39,742
Closed -$209K 2839
2023
Q1
$209K Buy
39,742
+17,750
+81% +$93.5K ﹤0.01% 677
2022
Q4
$61.8K Sell
21,992
-15,697
-42% -$44.1K ﹤0.01% 1039
2022
Q3
$156K Buy
37,689
+25,719
+215% +$106K ﹤0.01% 903
2022
Q2
$48K Buy
11,970
+10,912
+1,031% +$43.8K ﹤0.01% 1278
2022
Q1
$5K Buy
+1,058
New +$5K ﹤0.01% 1838
2021
Q4
Sell
-42,495
Closed -$425K 2967
2021
Q3
$425K Sell
42,495
-40,232
-49% -$402K ﹤0.01% 888
2021
Q2
$1.17M Buy
82,727
+32,052
+63% +$454K ﹤0.01% 559
2021
Q1
$832K Sell
50,675
-12,756
-20% -$209K ﹤0.01% 595
2020
Q4
$1.31M Buy
63,431
+47,408
+296% +$981K ﹤0.01% 409
2020
Q3
$122K Buy
+16,023
New +$122K ﹤0.01% 897
2020
Q2
Hold
0
2013
2020
Q1
Hold
0
1946
2019
Q4
Sell
-4,907
Closed -$15K 1934
2019
Q3
$15K Buy
+4,907
New +$15K ﹤0.01% 1062
2019
Q2
Hold
0
1809
2019
Q1
Sell
-10,827
Closed -$43K 1758
2018
Q4
$43K Sell
10,827
-6,745
-38% -$26.8K ﹤0.01% 913
2018
Q3
$121K Buy
+17,572
New +$121K ﹤0.01% 781
2018
Q2
Hold
0
1795
2018
Q1
Sell
-4,684
Closed -$21K 1732
2017
Q4
$21K Sell
4,684
-170
-4% -$762 ﹤0.01% 1089
2017
Q3
$30K Buy
+4,854
New +$30K ﹤0.01% 978
2017
Q2
Sell
-5,160
Closed -$48K 1675
2017
Q1
$48K Buy
5,160
+955
+23% +$8.88K ﹤0.01% 852
2016
Q4
$35K Sell
4,205
-2,537
-38% -$21.1K ﹤0.01% 897
2016
Q3
$46K Buy
+6,742
New +$46K ﹤0.01% 790
2016
Q2
Hold
0
1567
2016
Q1
Hold
0
1576
2015
Q4
Sell
-1,923
Closed -$27K 1696
2015
Q3
$27K Buy
+1,923
New +$27K ﹤0.01% 1052